Off-Label Drug Use and Fda Review of Supplemental Drug Applications

Hearing Before the Subcommittee on Human Resources and Intergovernmental Relations of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, Second Session; September 12, 1996